StockData
Phibro Animal Health Corp logo

Phibro Animal Health Corp (PAHC) stock

PAHCNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 21/3047% below fair value
$33.29−0.79 (-2.32%)

Close on Nov 20, 2026Market cap $1.35BP/E 13.7Yield 1.44%

Phibro Animal Health free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Phibro Animal Health's free cash flow for the twelve months ending Jun 30, 2026 was $9.87M, down 76.4% year over year. For fiscal 2026 it was $9.87M, down 76.4% from the year before. Over ten years it grew 27.5% a year on average. The highest annual figure on record is $77.51M in fiscal 2017.

Annual free cash flow

PeriodPeriod endValueChange
FY2026Jun 30, 2026$9.87M-76.4%
FY2025Jun 30, 2025$41.83M-9.8%
FY2024Jun 30, 2024$46.36M–
FY2023Jun 30, 2023-$38.48M–
FY2022Jun 30, 2022-$5.40M-128.4%
FY2021Jun 30, 2021$18.99M-25.0%
FY2020Jun 30, 2020$25.30M+46.4%
FY2019Jun 30, 2019$17.28M-66.4%
FY2018Jun 30, 2018$51.46M-33.6%
FY2017Jun 30, 2017$77.51M+8849.8%
FY2016Jun 30, 2016$866.00K-98.2%
FY2015Jun 30, 2015$48.65M–
FY2014Jun 30, 2014-$20.56M–
FY2013Jun 30, 2013-$18.51M-207.8%
FY2012Jun 30, 2012$17.16M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026$5.23M-35.7%
Q3 FY2026CQ1 2026Mar 31, 2026$890.00K-97.5%
Q2 FY2026CQ4 2025Dec 31, 2025$8.26M–
Q1 FY2026CQ3 2025Sep 30, 2025-$4.50M-248.2%
Q4 FY2025CQ2 2025Jun 30, 2025$8.13M-47.1%
Q3 FY2025CQ1 2025Mar 31, 2025$35.41M+2011.4%
Q2 FY2025CQ4 2024Dec 31, 2024-$4.75M-123.0%
Q1 FY2025CQ3 2024Sep 30, 2024$3.04M-65.2%
Q4 FY2024CQ2 2024Jun 30, 2024$15.36M+64.3%
Q3 FY2024CQ1 2024Mar 31, 2024$1.68M–
Q2 FY2024CQ4 2023Dec 31, 2023$20.60M–
Q1 FY2024CQ3 2023Sep 30, 2023$8.72M–
Q4 FY2023CQ2 2023Jun 30, 2023$9.35M–
Q3 FY2023CQ1 2023Mar 31, 2023-$1.65M–
Q2 FY2023CQ4 2022Dec 31, 2022-$12.31M-199.0%
Q1 FY2023CQ3 2022Sep 30, 2022-$33.87M–
Q4 FY2022CQ2 2022Jun 30, 2022-$10.32M–
Q3 FY2022CQ1 2022Mar 31, 2022-$3.88M-142.5%
Q2 FY2022CQ4 2021Dec 31, 2021$12.43M-36.6%
Q1 FY2022CQ3 2021Sep 30, 2021-$3.63M–
Q4 FY2021CQ2 2021Jun 30, 2021-$4.02M–
Q3 FY2021CQ1 2021Mar 31, 2021$9.14M-52.2%
Q2 FY2021CQ4 2020Dec 31, 2020$19.60M-17.1%
Q1 FY2021CQ3 2020Sep 30, 2020-$5.72M–
Q4 FY2020CQ2 2020Jun 30, 2020-$6.20M-230.2%
Q3 FY2020CQ1 2020Mar 31, 2020$19.10M+138.8%
Q2 FY2020CQ4 2019Dec 31, 2019$23.65M+154.6%
Q1 FY2020CQ3 2019Sep 30, 2019-$11.25M–
Q4 FY2019CQ2 2019Jun 30, 2019$4.76M+4.0%
Q3 FY2019CQ1 2019Mar 31, 2019$8.00M-57.1%
Q2 FY2019CQ4 2018Dec 31, 2018$9.29M-67.3%
Q1 FY2019CQ3 2018Sep 30, 2018-$4.77M–
Q4 FY2018CQ2 2018Jun 30, 2018$4.58M-43.3%
Q3 FY2018CQ1 2018Mar 31, 2018$18.64M-42.2%
Q2 FY2018CQ4 2017Dec 31, 2017$28.44M+31.5%
Q1 FY2018CQ3 2017Sep 30, 2017-$195.00K-101.3%
Q4 FY2017CQ2 2017Jun 30, 2017$8.07M–
Q3 FY2017CQ1 2017Mar 31, 2017$32.26M–
Q2 FY2017CQ4 2016Dec 31, 2016$21.62M–
Q1 FY2017CQ3 2016Sep 30, 2016$15.55M–

More Phibro Animal Health figures

See a number that looks wrong?